TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $235M (100.0% shares, 0.0% debt)

Holdings (22)

COGT Cogent Biosciences, Inc. 13.3%
Value $31.4M Shares 3,481,042 Est. Cost $8.31 Unrealized -17.9%
Iveric Bio, Inc. 11.9%
Value $28.04M Shares 2,914,250 Est. Cost $15.78 Unrealized
GERN Geron Corporation 9.9%
Value $23.4M Shares 15,096,342 Est. Cost $1.13 Unrealized +24.9%
KURA Kura Oncology, Inc. 9.1%
Value $21.4M Shares 1,167,642 Est. Cost $14.41 Unrealized -0.2%
CymaBay Therapeutics, Inc. 7.4%
Value $17.42M Shares 5,905,400 Est. Cost $3.38 Unrealized
ACRS Aclaris Therapeuitics, Inc. 6.8%
Value $15.98M Shares 1,144,939 Est. Cost $15.07 Unrealized -7.0%
VRDN Viridian Therapeutics Inc 6.5%
Value $15.2M Shares 1,314,000 Est. Cost $18.63 Unrealized -27.9%
Chinook Therapeutics, Inc. 5.9%
Value $13.93M Shares 796,460 Est. Cost $16.31 Unrealized
Aerovate Therapeutics, Inc. 5.9%
Value $13.9M Shares 889,572 Est. Cost $12.06 Unrealized
TRDA Entrada Therapeutics, Inc. 3.4%
Value $8.084M Shares 663,694 Est. Cost $17.12 Unrealized
Merus N.V. 2.9%
Value $6.792M Shares 300,000 Est. Cost $30.46 Unrealized
TYRA Tyra Biosciences, Inc. 2.7%
Value $6.409M Shares 896,418 Est. Cost $19.46 Unrealized -59.1%
Akouos, Inc. 2.7%
Value $6.332M Shares 1,350,006 Est. Cost $7.65 Unrealized
TNGX Tango Therapeutics, Inc. 2.3%
Value $5.31M Shares 1,172,250 Est. Cost $8.67 Unrealized -30.1%
MLTX MoonLake Immunotherapeutics 2.2%
Value $5.25M Shares 1,000,000 Est. Cost $6.29 Unrealized 0.0%
Alpine Immune Sciences, Inc. 2.1%
Value $4.921M Shares 578,260 Est. Cost $13.85 Unrealized
89bio, Inc. 1.6%
Value $3.649M Shares 1,133,196 Est. Cost $3.22 Unrealized
ZLAB Zai Lab LTD-ADR 1.4%
Value $3.295M Shares 95,000 Est. Cost $62.85 Unrealized
Magenta Therapeutics, Inc. 1.1%
Value $2.549M Shares 2,124,122 Est. Cost $4.43 Unrealized
ANAB AnaptysBio, Inc. 0.5%
Value $1.188M Shares 58,515 Est. Cost $30.26 Unrealized -26.8%
Elevation Oncology, Inc. 0.3%
Value $777K Shares 555,000 Est. Cost $6.02 Unrealized
Pardes Biosciences, Inc. 0.1%
Value $181K Shares 59,039 Est. Cost $7.22 Unrealized